The FDA has released a statement saying it will “carefully shepherd” studies to advance the development of chimeric antigen receptor T-cell therapies in autoimmune and rheumatic diseases.“It is quite ...
Growing antimicrobial resistance is prompting renewed interest in phage therapy, with preliminary data indicating improved outcomes when combined with standard antibiotics.
Faron Pharmaceuticals Ltd | Company announcement | April 09, 2026 at 20:25:00 EEST Faron publishes final results of its EUR 40.1 million rights issue NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRE ...
Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced that the company received a complete ...
inews.co.uk on MSN
Five early signs of bowel cancer everyone should know
It's the UK’s second biggest cancer killer but if it's diagnosed early, it's entirely treatable ...
Smart beta strategy blends passive and active investing, focusing on volatility, quality, and value factors. Learn how it ...
Perovskite solar cells shouldn’t work as well as they do—but they do. Scientists have now discovered that defects inside the material actually help, creating networks that separate and guide electric ...
Looking for the best cell phone service provider? Consumer Reports has honest ratings and reviews on cell phone service providers from the unbiased experts you can trust.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results